Investigating how specific receptors in the brain can help manage obesity and related diseases.
Melanocortin Receptor Selective Ligands
This study is looking at a brain receptor that helps control hunger and energy use, with the goal of finding new medicines that could help people with obesity and type 2 diabetes feel better and manage their weight without unwanted side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10841515 on NIH RePORTER |
What this research studies
This research focuses on the melanocortin-3 receptor (MC3R) in the brain, which plays a role in regulating energy balance and food intake. The project aims to discover selective ligands that can target this receptor, potentially leading to new treatments for obesity and related conditions like type 2 diabetes. Researchers will use both wild type and knockout mice to evaluate the effectiveness of these ligands in controlling appetite and metabolism. By understanding the MC3R's role, the study hopes to develop therapies that minimize side effects associated with current treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with obesity or related metabolic disorders, particularly those with type 2 diabetes.
Not a fit: Patients who are not overweight or do not have metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic options for managing obesity and its associated health risks.
How similar studies have performed: Previous research has shown promise in targeting similar receptors for obesity treatment, indicating potential for success in this approach.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Haskell-Luevano, Carrie — University of Minnesota
- Study coordinator: Haskell-Luevano, Carrie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.